Reuters logo
BRIEF-Vicore Pharma: phase I extension study demonstrates beneficial effects on lipid metabolism with C21
October 2, 2017 / 6:10 AM / 2 months ago

BRIEF-Vicore Pharma: phase I extension study demonstrates beneficial effects on lipid metabolism with C21

Oct 2 (Reuters) - VICORE PHARMA HOLDING AB:

* PHASE I EXTENSION STUDY DEMONSTRATES BENEFICIAL EFFECTS ON LIPID METABOLISM WITH C21

* ANNOUNCE POSITIVE RESULTS FROM IN-DEPTH ANALYSIS OF PHASE I EXTENSION STUDY WITH ITS CANDIDATE DRUG NAMED C21 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below